TCM
COYA icon

Triumph Capital Management’s Coya Therapeutics COYA Stock Holding History

Triumph Capital Management’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$292 Hold
50
– – ﹤0.01% 1779
2026
Q1 		$197 Hold
50
– – ﹤0.01% 1766
2025
Q4 		$290 Buy
+50
New +$304 ﹤0.01% 1699

Other funds holding COYA

GIA
GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return
BL
BFSG LLC Irvine, California $1.13B AUM 29.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Triumph Capital Management's COYA Position: Q2 2026 in Review

Triumph Capital Management held its Coya Therapeutics (COYA) position steady in Q2 2026 at 50 shares worth $292. The position accounts for ﹤0.01% of the portfolio, ranked #1779.

Triumph Capital Management first reported a position in COYA in Q4 2025 and has held it in 3 quarters since. 5 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

  • Triumph Capital Management held 50 shares of Coya Therapeutics worth $292 as of Q2 2026.
  • Triumph Capital Management left its Coya Therapeutics share count unchanged in Q2 2026.
  • Coya Therapeutics made up ﹤0.01% of Triumph Capital Management's portfolio in Q2 2026, its #1779 holding.
  • Triumph Capital Management first reported a position in Coya Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 5 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on Triumph Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.